Product Information

CYCLOBENZAPRINE 5 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.0222 per EA under NDC 68084075365. Its NADAC has been published 135 times since Apr 17, 2024.

FDA first approved this application on Feb 28, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CYCLOBENZAPRINE 5 MG TABLET

Cyclobenzaprine Hydrochloride
$0.0222per EA

Strength

5 mg/1

NDC

68084075365

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA078048

FDA Approved

2/28/2011

TE Code

AB

On Market Since

1/4/2016

Pharmacological Classes

Centrally-mediated Muscle Relaxation
Muscle Relaxant

Price Statistics

The NADAC for CYCLOBENZAPRINE 5 MG TABLET has been published 135 times since Apr 17, 2024, and over the history we have for it it has risen 23.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0222 per EA
All-time high$0.0232 (Nov 13, 2024)
All-time low$0.0157 (Nov 20, 2024)
52-week high$0.0222
52-week low$0.0209
Median price$0.0216
Average price$0.0209
Largest weekly change+36.3% (Aug 21, 2024)
Weeks tracked135
Tracking sinceApr 17, 2024

Price History

1W

0.0%

1M

+0.9%

3M

+5.0%

6M

+5.2%

1Y

+2.1%

3Y

N/A

5Y

N/A

All

+23.3%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CYCLOBENZAPRINE 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 5 MG TABLET, manufactured by American Health Packaging, is $0.0222 per EA (NDC 68084075365), effective Nov 11, 2026.

How has the price of CYCLOBENZAPRINE 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has risen 23.3%. It has been tracked across 135 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 5 MG TABLET?

Since Apr 17, 2024, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has ranged from a low of $0.0157 (Nov 20, 2024) to a high of $0.0232 (Nov 13, 2024), with a median of $0.0216 per EA.

Are there cheaper alternatives to CYCLOBENZAPRINE 5 MG TABLET?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CYCLOBENZAPRINE 5 MG TABLET, is $0.0220 per EA — about 1% below CYCLOBENZAPRINE 5 MG TABLET.

Who manufactures CYCLOBENZAPRINE 5 MG TABLET?

CYCLOBENZAPRINE 5 MG TABLET (NDC 68084075365) is labeled by American Health Packaging, and CMS classifies it as a generic product.